Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/29/2009 | US7595057 Streptococcus pyogenes antigens and corresponding DNA fragments |
09/29/2009 | US7595051 Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies |
09/29/2009 | US7595050 Human IGM monoclonal antibody capable of inducing apoptosis in HIV-infected cells |
09/29/2009 | US7595049 Monoclonal antibody for prevention and treatment of human immunodeficiency viral infection; immunotherapy |
09/29/2009 | US7595044 Artery-and vein-specific proteins and uses therefor |
09/29/2009 | CA2446741C Ophthalmic drug delivery device |
09/29/2009 | CA2425852C Cytomegalovirus intron a fragments |
09/29/2009 | CA2404163C Production of recombinant blood clotting factors in human cell lines |
09/29/2009 | CA2372508C Sensor for microfluid handling system |
09/29/2009 | CA2368495C Electron-deficient nitrogen heterocycle-substituted fluorescein dyes |
09/29/2009 | CA2293489C Inhibitors of dna immunostimulatory sequence activity |
09/29/2009 | CA2250118C Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
09/29/2009 | CA2240737C A long qt syndrome gene which encodes kvlqt1 and its association with mink |
09/29/2009 | CA2194660C Growth differentiation factor-11 |
09/29/2009 | CA2184297C Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
09/29/2009 | CA1341598C Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex |
09/24/2009 | WO2009117698A2 Methods of rna amplification in the presence of dna |
09/24/2009 | WO2009117656A2 Capsid-incorporated antigen for novel adenovirus vaccine |
09/24/2009 | WO2009117595A2 Sequence variations on chromosome 15 predicting risk for lung cancer |
09/24/2009 | WO2009117555A1 Floral dip method for transformation of camelina |
09/24/2009 | WO2009117553A2 Enhancing vessel lesion homing and repair potential of stem cells |
09/24/2009 | WO2009117541A1 Composition for imaging reagent |
09/24/2009 | WO2009117539A2 Bioluminescent construct |
09/24/2009 | WO2009117513A2 Modified dicer polypeptide and methods of use thereof |
09/24/2009 | WO2009117423A2 High lycopene content tomato plants and markers for use in breeding for same |
09/24/2009 | WO2009117417A2 Chimeric promoters and their uses thereof in plants |
09/24/2009 | WO2009117415A2 Genetic indicators of weight loss |
09/24/2009 | WO2009117346A2 System and method for determining the health of a subject using polymorphic risk markers |
09/24/2009 | WO2009117327A2 Compositions and methods for analysis of nucleic acid molecules during amplification reactions |
09/24/2009 | WO2009117307A2 Viruses lacking epithelial cell receptor entry |
09/24/2009 | WO2009117122A2 Genetic analysis |
09/24/2009 | WO2009117004A1 Reagents and methods for use in head and neck cancer diagnosis, classification and therapy |
09/24/2009 | WO2009116863A2 Expression-linked gene discovery |
09/24/2009 | WO2009116670A1 Anti-human dlk-1 antibody having anti-tumor activity in vivo |
09/24/2009 | WO2009116639A1 Partial peptide of lacritin |
09/24/2009 | WO2009116599A1 Method for testing type ii diabetes |
09/24/2009 | WO2009116592A1 Method for detection of cancer cell induced by hpv, method for determination concerning whether or not tissue is in later stage of severe dysplasia, and primer set and kit for use in the methods |
09/24/2009 | WO2009116566A1 Industrially useful microorganism |
09/24/2009 | WO2009116529A1 Polypeptide and pharmaceutical composition containing the polypeptide |
09/24/2009 | WO2009116524A1 Modified protein |
09/24/2009 | WO2009116286A1 Flocculent yeast and method for production thereof |
09/24/2009 | WO2009116268A1 Method for quantification of soluble lr11 |
09/24/2009 | WO2009115834A2 Hormone inhibition |
09/24/2009 | WO2009115822A1 Nrps-pks gene cluster and its manipulation and utility |
09/24/2009 | WO2009115809A2 Thyroid stimulating hormone fusion proteins |
09/24/2009 | WO2009115760A2 Container for receiving and storing biological material, especially dna |
09/24/2009 | WO2009115664A2 Crystalline structure of the cc2-lz domain of nemo |
09/24/2009 | WO2009115660A2 In vivo selection |
09/24/2009 | WO2009115569A1 Developmental stage-specific lethality system for insect population control |
09/24/2009 | WO2009115561A1 Polynucleotides and chimaera polypeptides for releasing a polypeptide of interest combined with exosomes and use thereof for the production of immunogenic compositions |
09/24/2009 | WO2009115509A2 Antigenic protein fragments of streptococcus pneumoniae |
09/24/2009 | WO2009115497A1 Polypeptide having glyoxalase iii activity, polynucleotide encoding the same and uses thereof |
09/24/2009 | WO2009115465A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
09/24/2009 | WO2009115295A1 Vectors and methods for generating vector-free induced pluripotent stem (ips) cells using site-specific recombination |
09/24/2009 | WO2009115114A1 Polypeptide having glyoxylase iii activity, polynucleotide encoding the same and uses thereof |
09/24/2009 | WO2009114949A1 Methods for deprogramming somatic cells and uses thereof |
09/24/2009 | WO2009114942A1 Thymidylate kinase fusions and uses thereof |
09/24/2009 | WO2009114939A1 Aromatic prenyltransferase from hop |
09/24/2009 | WO2009114922A1 System and method for micromanipulating samples |
09/24/2009 | WO2009097346A3 Isolated alcohol dehydrogenase enzymes and uses thereof |
09/24/2009 | WO2009097133A3 Transgenic plants with enhanced agronomic traits |
09/24/2009 | WO2009095517A3 Methods and compositions capable of causing post-transcriptional silencing of gene expression in a synergic manner |
09/24/2009 | WO2009094742A9 Toxin of the spider phoneutria nigriventer for treatment of erectile dysfunction |
09/24/2009 | WO2009094084A9 Enhanced protein production in bacillus |
09/24/2009 | WO2009091912A3 Improved mammalian expression vectors and uses thereof |
09/24/2009 | WO2009090594A3 Alphavirus based vectors |
09/24/2009 | WO2009085270A3 Use of inhibitors of c0nnexin43 for treatment of fibrotic conditions |
09/24/2009 | WO2009085269A3 Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions |
09/24/2009 | WO2009082148A3 Enhanced ethanol and butanol producing microorganisms and method for preparing ethanol and butanol using the same |
09/24/2009 | WO2009079729A3 Genotypes, alleles and molecular markers associated with asian soybean rust, as well as methods, processes and uses thereof |
09/24/2009 | WO2009076464A3 Methods for sequential replacement of targeted region by homologous recombination |
09/24/2009 | WO2009073820A3 Biopolymer-nucleic acid conjugation |
09/24/2009 | WO2009071488A3 Hcv ns3 protease replicon shuttle vectors |
09/24/2009 | WO2009070822A3 Recombinant pichia pastoris cell |
09/24/2009 | WO2009070805A3 Mir-124 regulated genes and pathways as targets for therapeutic intervention |
09/24/2009 | WO2009066320A3 Gcsf fusion protein systems suitable for high expression of peptides |
09/24/2009 | WO2009065912A3 Plants having increased yield-related traits and a method for making the same |
09/24/2009 | WO2009065618A3 Improvement of transfection results of non-viral gene delivery systems by influencing the congenital immune system |
09/24/2009 | WO2009061852A3 Modulation of factor 9 expression |
09/24/2009 | WO2009060429A3 Compositions for conferring tolerance to viral disease in social insects, and the use thereof |
09/24/2009 | WO2009045457A3 Tripartite rnai constructs |
09/24/2009 | WO2009045356A3 Microrna compositions in the treatment of vegf-mediated disorders |
09/24/2009 | WO2009040555A3 A method for generating a recombinant clonal cell line and novel reagents for use in the method |
09/24/2009 | WO2009023347A3 Metal resistant plants, and methods of manufacture thereof |
09/24/2009 | WO2009009900A8 Nucleic acid sequences for the amplification and detection of respiratory viruses |
09/24/2009 | WO2008101118A3 A gene expression signature identifying pro-angiogenic genes in ovarian tumor endothelial cell isolates |
09/24/2009 | WO2007136988A8 Compounds and methods for modulating expression of gccr |
09/24/2009 | WO2007056326A3 Compositions and methods for inhibiting expression of nav1.8 gene |
09/24/2009 | WO2004045516A9 Compositions and methods for the diagnosis and treatment of tumor |
09/24/2009 | WO2002079384A9 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
09/24/2009 | WO2002074932A3 Novel human kinase and polynucleotides encoding the same |
09/24/2009 | US20090241231 Plant senescence-inducible promoter |
09/24/2009 | US20090241230 Expression cassettes for seed-preferential expression in plants |
09/24/2009 | US20090241227 Expression cassettes for seed-preferential expression in plants |
09/24/2009 | US20090241226 Gene Encoding Lignan Methylation Enzyme |
09/24/2009 | US20090241225 Alteration of embryo/endosperm size during seed development |
09/24/2009 | US20090241224 Transgenic plant that expresses Rubisco Activase derived polypeptides, or nucleic acids that express the polypeptides, that are more thermostable than naturally occurring Rubisco Activase; expression or activity of endogenous Rubisco Activase of the plant may be eliminated; Arabidopsis |
09/24/2009 | US20090241223 Modulating plant sugar levels |
09/24/2009 | US20090241222 Tandem reapeat dna constructs producing proteins that attack plant pathogenic viruses, fungi, and bacteria by disrupting transcription factors essential for replication thereof in plants |
09/24/2009 | US20090241221 Tandem reapeat dna constructs producing proteins that attack plant pathogenic viruses, fungi, and bacteria by disrupting transcription factors essential for replication thereof in plants |